Inhibrx Biosciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Inhibrx Biosciences.

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for Inhibrx Biosciences is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Reni Benjamin Citizens Capital Markets	Citizens Capital Markets	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 18, 2025
Reni Benjamin JMP Securities	JMP Securities	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jan 22, 2025
Reni Benjamin JMP Securities	JMP Securities	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Jul 23, 2024
Reni Benjamin JMP Securities	JMP Securities	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jan 23, 2024
Reni Benjamin JMP Securities	JMP Securities	Buy Reiterates $27	Buy	Reiterates	$27	+96.51%	Nov 20, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 200.00K

Revenue Next Year

n/a

EPS This Year

-9.59

from 112.62

EPS Next Year

n/a

from -9.59

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	1.32M	1.80M	200.00K	-
Revenue Growth	-	36.88%	-88.89%	-
EPS	-	-20.48	112.62	-9.59
EPS Growth	-	-	-	-
Forward PE	-	-	-	-
No. Analysts	-	-	-	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2025
High	-
Avg	-
Low	-

EPS Forecast

EPS	2025
High	-7.05
Avg	-9.59
Low	-11.84

EPS Growth

EPS Growth	2025
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.